Healthy Living Europe
SEE OTHER BRANDS

Keeping up with healthcare and wellness news from Europe

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on April 15, 2025

Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

LONDON, Ontario and BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company, today announced that the Company’s Cell Pouch Bio-hybrid Organ in clinical …

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- NeuroNOS, a biopharmaceutical company focused on developing transformative treatments for Autism Spectrum Disorder (ASD) and Alzheimer’s disease (AD)conditions, and a subsidiary of Beyond Air (NASDAQ: XAIR), is …

Healthcare Integrated Technologies Inc. Appoints Sasidhar Valluru as Director of Global Product Delivery

Healthcare Integrated Technologies Inc. Appoints Sasidhar Valluru as Director of Global Product Delivery

Mr. Valluru Joins to Strengthen HITC’s Global Technology Operations Knoxville, TN, April 15, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces …

Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer

Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer

- Initial results from randomized Phase 2 CRDF-004 trial in RAS-mut mCRC were released in December 2024 - - Additional clinical data from CRDF-004 trial expected in 1H 2025 - SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: …

Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025

Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025

PHILADELPHIA, April 15, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today …

Inventiva announces filing of its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F

Inventiva announces filing of its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F

Daix (France), New York City (New York, United States), April 15, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for …

Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2024  et de son Rapport Annuel 2024 (« Form 20-F »)

Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2024 et de son Rapport Annuel 2024 (« Form 20-F »)

Daix (France), New York City (New York, États-Unis), le 15 avril 2025 - Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par …

POPULUS Health Technologies Names Edith Hodkinson Chief Strategy Officer and Kim Levy VP of Marketing

POPULUS Health Technologies Names Edith Hodkinson Chief Strategy Officer and Kim Levy VP of Marketing

PRINCETON, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- POPULUS Health Technologies today announced that Edith Hodkinson has joined as Chief Strategy Officer. Edith brings over 25 years of experience in the healthcare industry leading digital innovation and …

Best Legal Steroids For Muscle Growth, Cutting, Buying Anabolic Steroids, Testosterone As A Steroid, Steroids For Sale, How To Get Steroids, Metabolic Steroids (By CrazyBulk)

Best Legal Steroids For Muscle Growth, Cutting, Buying Anabolic Steroids, Testosterone As A Steroid, Steroids For Sale, How To Get Steroids, Metabolic Steroids (By CrazyBulk)

NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Using Steroids for Bodybuilding Bodybuilding with steroids is usually divided into two parts: the bulking phase and the cutting phase. Bulking is for gaining muscle and strength, while cutting is for losing fat …

Elumina Health Announces The Launch of New AI Capability in BasisEHR—The First AI-Powered EHR for Post-Acute Home Healthcare

Elumina Health Announces The Launch of New AI Capability in BasisEHR—The First AI-Powered EHR for Post-Acute Home Healthcare

COLUMBUS, Ohio, April 15, 2025 (GLOBE NEWSWIRE) -- Elumina Health Inc announces the launch of AI based patient risk triaging capability in Basis EHR. Basis EHR leverages AI to identify home healthcare patients who are at high risk for hospitalization on …

New Documentary "Steps Ahead" from Health Monitor Network Tackles Critical Issue of Health Equity

New Documentary "Steps Ahead" from Health Monitor Network Tackles Critical Issue of Health Equity

Montvale, NJ, April 15, 2025 (GLOBE NEWSWIRE) -- Health Monitor Network released a documentary film short, Steps Ahead, which spotlights the critical issue of health equity, as well as the vital role community advocacy and health literacy play in bridging …

Hospital and pre-hospital External Defibrillator Market to Reach $3.4 Billion By 2027 in the short run and $5.5 Billion By 2035 Globally, at 6.1% CAGR: AMR

Hospital and pre-hospital External Defibrillator Market to Reach $3.4 Billion By 2027 in the short run and $5.5 Billion By 2035 Globally, at 6.1% CAGR: AMR

Wilmington, Delaware, April 15, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Hospital and Pre-hospital External Defibrillator Market - Global Opportunity Analysis and Industry Forecast, 2024-2035", was valued at $2.7 billion …

Best Steroids For Muscle Gain, Cutting, Steroid For Muscle Mass, Anabolic Steroids For Muscle Growth, Do Bodybuilders Take Steroids, Muscle Growth Steroids (By CrazyBulk)

Best Steroids For Muscle Gain, Cutting, Steroid For Muscle Mass, Anabolic Steroids For Muscle Growth, Do Bodybuilders Take Steroids, Muscle Growth Steroids (By CrazyBulk)

NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- When you stop making progress after years of dieting and weight lifting, you know it’s time to try something new. You want ways to speed up your muscle growth and reach the body of your dreams. This is where a …

Best Steroids For Muscle Growth, Cutting, Muscle Building Steroids, Is Testosterone a Steroid, Buy Legal Steroids, Steroid to Build Muscle, Purchase Steroids (By CrazyBulk)

Best Steroids For Muscle Growth, Cutting, Muscle Building Steroids, Is Testosterone a Steroid, Buy Legal Steroids, Steroid to Build Muscle, Purchase Steroids (By CrazyBulk)

NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Natural, safe, …

Best Muscle Growth Steroids, Cutting, Anabolic Steroids For Bodybuilding, Is Steroids Testosterone, Do Bodybuilders Use Steroids, Steroids For Muscles (By CrazyBulk)

Best Muscle Growth Steroids, Cutting, Anabolic Steroids For Bodybuilding, Is Steroids Testosterone, Do Bodybuilders Use Steroids, Steroids For Muscles (By CrazyBulk)

NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- I have worked with many bodybuilders over 30 years, from professionals to beginners. People often ask me what the most effective steroid is for building huge muscles. The answer is Dianabol (also known as Dbol). …

BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory

BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory

KUALA LUMPUR, Malaysia, April 15, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) (“BioNexus” or the “Company”), a diversified biotechnology and specialty materials group headquartered in Malaysia and incorporated in Wyoming, today …

During Oral Cancer Awareness Month, Benevis Raises Visibility for the Importance of Early Detection Through Routine Dental Care

During Oral Cancer Awareness Month, Benevis Raises Visibility for the Importance of Early Detection Through Routine Dental Care

Atlanta, GA, April 15, 2025 (GLOBE NEWSWIRE) -- During April’s Oral Cancer Awareness Month, Benevis joins its dental industry peers in efforts to highlight the importance of good oral hygiene and proactive risk assessments for the disease. Oral cancer is …

Er-Kim Announces Exclusive Distribution Agreement with Polaris Pharmaceuticals to Commercialize Pegargiminase (ADZODI) for  Malignant Pleural Mesothelioma (MPM) in Multiple EMEA Markets

Er-Kim Announces Exclusive Distribution Agreement with Polaris Pharmaceuticals to Commercialize Pegargiminase (ADZODI) for Malignant Pleural Mesothelioma (MPM) in Multiple EMEA Markets

ATHENS, Greece and SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Er-Kim Pharmaceuticals, an international company specializing in the commercialization of novel therapies for pharmaceutical and biopharmaceutical companies, today announced it has signed a …

HealthEquity’s Expedited Claims Technology Wins Artificial Intelligence Excellence Awards

HealthEquity’s Expedited Claims Technology Wins Artificial Intelligence Excellence Awards

DRAPER, Utah, April 15, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity"), the nation’s largest Health Savings Account (HSA) administrator, has been recognized by the Business Intelligence Group for its Expedited Claims AI system …

Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems

Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems

RA'ANANA, Israel, April 15, 2025 (GLOBE NEWSWIRE) -- RA'ANANA, Israel, April 15, 2025 -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service